People News

Share this article:
Seattle Genetics, a biotech focused on development and commercialization of monoclonal antibody-based therapies for cancer and autoimmune disease, announced the appointment of Bruce Seeley as EVP, commercial. The company also announced the promotion of Kirk Schumacher to VP, legal affairs and compliance, and general counsel. Seeley was most recently a senior marketing director at Genentech, for Herceptin and T-DM1. Schumacher was most recently general counsel at Seattle Genetics.

Publicis Strategic Solutions Group
named Christopher Dowd EVP, business development. In his new role, Dowd is responsible for leading business development activities, and reports to Rick Keefer, president and CEO. Dowd was most recently president of sales at Allergan.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media